You can save this page to your desktop by using Add to Home Screen.
Home Blog Page 2
Dossier organizes and documents learning, skills and experience effectively, ensuring operational quality and patient safety. This includes On-the-Job-Training, procedures, e-learning and certifications, as well as end-user introductions to complex digital solutions like EMR/HER and medical devices. We assist more than 350 000 healthcare professionals across the Nordics in reducing time spent on competency management, while assuring compliance.  
The antidepressant fluoxetine has been suggested as a means to improve brain recovery after acute stroke. However, a large randomised study on stroke patients at 35 Swedish hospitals shows that the drug has no such effect. The study, which was led by researchers at Karolinska Institutet, is published in The Lancet Neurology. Erik Lundström, researcher at the Department of Clinical...
A new joint report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) presents the largest venture ever on precision medicine in diabetes. The report includes a detailed overview and roadmap for how this new approach to diabetes medicine can be evaluated and implemented into clinical practice. The role of precision diabetes medicine...
A new way of identifying cancer biomarkers has been developed by researchers at Lund University in Sweden. The new technology allows very sensitive, quick and cost-effective identification of cancer biomarkers. The research is published in Nature Communications Biology. Today, every third person will get cancer in their lifetime, and the current trend suggests that in a few years that number...
Zelluna Immunotherapy
Zelluna Immunotherapy is a privately-owned Norwegian biopharmaceutical company founded in 2016. The goal is to revolutionize cancer therapy by developing TCR based immunotherapies with the potential to treat a wide range of solid tumours and patients. Zelluna has a broad portfolio of TCRs derived from both CD4 and CD8 T cell clones. The TCRs have been tailored by the immune system of long-term...
airnum
Airinum in Stockholm, Sweden is a successful company that offers an anti-pollution breathing mask to poor air quality, one of the world’s largest indirect health risks according to the World Health Organization . The company has also been boosted by the ongoing COVID-19 pandemic and the global demand for breathing masks. The key to the protection is five layers of protection, each layer with...
NEWS Treatment of the common disease psoriasis, usually focuses on treating the skin. However, psoriasis patients often have other physical diseases that can bring on depression, anxiety, and suicide. A new study from Umeå University, Sweden, shows that these other somatic diseases have even more impact on patients’ mental health than their skin symptoms, highlighting the importance of holistic patient...
New research from Karolinska Institutet and Karolinska University Hospital shows that many people with mild or asymptomatic COVID-19 demonstrate so-called T-cell-mediated immunity to the new coronavirus, even if they have not tested positively for antibodies. According to the researchers, this means that public immunity is probably higher than antibody tests suggest. The article is freely available on the bioRxiv...
The vitality of preterm infants should be assessed with an Apgar score, a tool used to measure the health of newborns immediately after birth. That is the conclusion by researchers at Karolinska Institutet in Sweden who in a large observational study examined the value of Apgar scores for preterm infants. The findings are published in the New England Journal...
Using genetically modified cells, researchers from Uppsala University hope to create a treatment for Glioblastoma, an aggressive brain cancer as of today lacking a cure. “Our ambition is to start clinical studies within four years”, says Magnus Essand, Professor of Gene Therapy. Immuno-oncology, the method of taking advantage of the body’s own immune system against cancer cells, is an upcoming...
- Advertisement -
- Advertisement -
- Advertisement -